Navigation Links
HealthSouth Reports Results for Third Quarter Ended September 30, 2008
Date:11/4/2008

Adjusted Consolidated EBITDA are non-GAAP financial measures. Management and some members of the investment community utilize adjusted income (loss) from continuing operations as a financial measure and Adjusted Consolidated EBITDA as a liquidity measure on an ongoing basis. These measures are not recognized in accordance with GAAP and should not be viewed as an alternative to GAAP measures of performance or liquidity. In evaluating these adjusted measures, the reader should be aware that in the future HealthSouth may incur expenses similar to the adjustments set forth above.

(2) Per share amounts for the three months ended September 30, 2008 and 2007 are based on basic weighted average common shares outstanding for all amounts except adjusted income (loss) from continuing operations per diluted share, which is based on diluted shares outstanding. The diluted share counts for the three months ended September 30, 2008 and 2007 contain 13.1 million shares related to the potential dilution of the Company's convertible perpetual preferred stock. Per share amounts do not include 5.0 million shares of common stock or warrants to purchase approximately 8.2 million shares of common stock not yet issued under the securities litigation settlement. The increase in the Company's basic and diluted weighted average common shares outstanding for the three months ended September 30, 2008 compared to the same period of 2007 was primarily the result of its equity offering of 8.8 million shares that was completed on June 27, 2008. The calculation of adjusted loss from continuing operations per diluted share ignores the antidilutive impact in 2007.

(3) Adjusted income (loss) from continuing operations per diluted share and Adjusted Consolidated EBITDA are two components of the Company's guidance.

(4) The Company's Credit Agreement allows certain items to be added to arrive at Adjusted Consolidated EBITDA that are viewed as not being ongoing costs once the Company
'/>"/>

SOURCE HealthSouth Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

Related medicine news :

1. HealthSouth Declares Dividend on 6.5% Series A Convertible Perpetual Preferred Stock
2. HealthSouth Corporation Appoints New Member to Board of Directors
3. HealthSouth Announces Date of Third Quarter Earnings Conference Call
4. HealthSouth and Physicians Pay $14.9 Million to Settle Health Care Fraud Claims
5. HealthSouth Announces Final Agreement on Previously Disclosed Settlement with Federal Government
6. HealthSouth Issues Statement on Medicare Bill and 75% Rule
7. HealthSouth Declares Dividend on 6.5% Series A Convertible Perpetual Preferred Stock
8. HealthSouth Reports Results for Fourth Quarter Ended December 31, 2007
9. HealthSouth to Present at the Lehman Brothers Eleventh Annual Global Healthcare Conference and the 2008 Credit Suisse Global Leveraged Finance Conference
10. HealthSouth Finalizes Sale of Corporate Campus to Daniel Corporation
11. HealthSouth Announces Date of 2008 First Quarter Earnings Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2009)... hired Deirdre Byrne to lead the firm’s Interim Leadership division as ... experience in healthcare consulting, Byrne will assume her duties at B. ... ... 17, 2009 -- B. E. Smith recently hired Deirdre ... president. A seasoned executive with nearly 20 years of experience in ...
(Date:12/17/2009)... 17 Motionsoft, Inc. announced today that ... Industry (PCI) Data Security Standards (DSS) certification, making ... vendors in the health and wellness space that ... Standard is the result of a collaborative effort ... (Visa International, MasterCard Worldwide, American Express, Discover Financial ...
(Date:12/17/2009)... PHILADELPHIA, Dec. 17 The recently opened ... already out in the community in full force this ... Run on December 13th, benefiting the Arthritis Foundation, a ... of arthritis. The event boasted 1,500 attendees, spotlighting LSI,s ... Run is a renowned, national fundraiser and a festive ...
(Date:12/17/2009)... S-transferase M1 (GSTM1) and glutathione S-transferase T1 (GSTT1) null ... cancer. The results regarding the association between GSTM1 and ... CRC were contradictory. However, the majority of previous reports ... association of the GSTM1/GSTT1 null genotype with the risk ... studies with larger numbers of samples. , A ...
(Date:12/17/2009)... 2009) Researchers from the La Jolla Institute for Allergy ... world,s most dangerous infectious diseases tuberculosis, malaria and ... set of projects seeking to make new inroads toward ... received four project awards totaling $18.8 million from the ... of the National Institutes of Health, to fund the ...
Breaking Medicine News(10 mins):Health News:Deirdre Byrne Joins B. E. Smith as Senior Vice President, Interim Leadership Services 2Health News:Deirdre Byrne Joins B. E. Smith as Senior Vice President, Interim Leadership Services 3Health News:Motionsoft Completes PCI Compliance Certification 2Health News:Laser Spine Institute (LSI) Supports Jingle Bell Run 2Health News:NIH awards La Jolla Institute $18.8 million for major infectious disease study 2Health News:NIH awards La Jolla Institute $18.8 million for major infectious disease study 3Health News:NIH awards La Jolla Institute $18.8 million for major infectious disease study 4Health News:NIH awards La Jolla Institute $18.8 million for major infectious disease study 5
... Network for Organ Sharing which oversees the U.S. organ transplant ... hospitals that it is assigned to supervise// according to the ... newspaper when it does act, its findings are usually kept ... risks, such as including excessive death rates. ,This ...
... health problems and hurting outdoor-related businesses in Singapore is ... ,The prolonged pall that has enveloped Southeast ... when the northeast monsoon douses the fires raging in ... October prediction. ,Experts said intermittent showers are ...
... In a finding that may provide a scientific basis ... brain injury reduces the level of a protein that// ... activity, in turn, is thought to be an underlying ... who have suffered a traumatic brain injury (TBI). ...
... eating apples this time of year is just for fun ... may want to think again. //Apples and apple juice may ... their diet, finds a collection of recent research studies, the ... Neuroscience annual conference in Atlanta. Researchers G. Bureau and M. ...
... brain chemical dopamine has always been considered as a 'pleasure ... a manner which extols a person or animal for the ... has shown that certain drugs like cocaine and heroin can ... new study from the University of Michigan adds a new ...
... setting up the "Katrina Clinic" at the Astrodome/Reliant Center ... a medical response to disasters //and other large-scale ... the Southern Medical Journal (SMJ), official journal of the ... of Baylor College of Medicine and colleagues relate and ...
Other Medicine News:Health News:Flaws Reported in overview of US organ transplants 2Health News:How Brain Injury Leads to Seizures, Memory Problems 2Health News:Pick Apples for Good Neurological Health, Says New Research 2Health News:Authors Review Astrodome Medical Response to Hurricane Katrina 2Health News:Authors Review Astrodome Medical Response to Hurricane Katrina 3
(Date:12/17/2009)... ANGELES, Dec. 17 Instacare Corp. (OTC ... life-saving and life-enhancing prescription drugs and diagnostics and ... and a leading developer and provider of e-health ... products announced today that as part of the ... has determined to add two new Directors and ...
(Date:12/17/2009)... Resources, one of the world,s leading research and ... finds that over 70 percent of surveyed U.S. ... diabetes drugs with novel mechanisms of action versus ... need for additional DPP-IV inhibitors. Both surveyed physicians ... ability and physicians in particular say the most ...
(Date:12/17/2009)... N.J., Dec. 17 BASF ... has approved the use of Aseptrol® S10 - ... industrial facilities, such as, schools, hospitals, government buildings, ... S10 - Tab is based on Chlorine dioxide ... delivers a broad spectrum disinfectant as stated ...
Breaking Medicine Technology:Instacare Corp. Board of Directors Sets Growth Plans for 2010 2Over 70 Percent of Physicians Say There Is a High Need for More Diabetes Drugs with Novel Mechanisms of Action While 15 Percent Say the Same for DPP-IV Inhibitors 2Over 70 Percent of Physicians Say There Is a High Need for More Diabetes Drugs with Novel Mechanisms of Action While 15 Percent Say the Same for DPP-IV Inhibitors 3BASF's Aseptrol(R) S10 - Tab Receives EPA Approval For H1N1 Sanitization Label 2BASF's Aseptrol(R) S10 - Tab Receives EPA Approval For H1N1 Sanitization Label 3Valeritas Announces Appointment of New CEO 12391 1Valeritas Announces Appointment of New CEO 12391 2Valeritas Announces Appointment of New CEO 12391 3Researchers determine predicting factors of positive lung cancer diagnoses in chest radiographs 47488 117 million US children live more than an hour away from trauma care 47486 117 million US children live more than an hour away from trauma care 47486 2
... Micromet, Inc.,(Nasdaq: MITI ), a ... treatment of cancer, inflammation and autoimmune,diseases, presented ... American Association,for Cancer Research (AACR) in San ... levels of subcutaneously administered BiTE(R),antibodies(1). BiTE antibodies ...
... Micromet, Inc.,(Nasdaq: MITI ), a ... treatment of cancer, inflammation and autoimmune,diseases, presented ... Association for,Cancer Research (AACR) in San Diego, ... (Herceptin(R); Genentech, Roche),cetuximab (Erbitux(R); Bristol-Myers Squibb, Imclone, ...
Other Medicine Technology:Micromet Shows Feasibility of Subcutaneous Delivery of BiTE Antibody in Preclinical Primate Study 2Micromet Shows Feasibility of Subcutaneous Delivery of BiTE Antibody in Preclinical Primate Study 3Micromet Shows Feasibility of Subcutaneous Delivery of BiTE Antibody in Preclinical Primate Study 4Micromet Shows Feasibility of Subcutaneous Delivery of BiTE Antibody in Preclinical Primate Study 5Micromet Demonstrates That the Antibodies in Commercial Products Herceptin, Erbitux, Vectibix and Xolair Can Be Converted Into Highly Potent, T Cell- Engaging BiTE Antibodies 2Micromet Demonstrates That the Antibodies in Commercial Products Herceptin, Erbitux, Vectibix and Xolair Can Be Converted Into Highly Potent, T Cell- Engaging BiTE Antibodies 3Micromet Demonstrates That the Antibodies in Commercial Products Herceptin, Erbitux, Vectibix and Xolair Can Be Converted Into Highly Potent, T Cell- Engaging BiTE Antibodies 4Micromet Demonstrates That the Antibodies in Commercial Products Herceptin, Erbitux, Vectibix and Xolair Can Be Converted Into Highly Potent, T Cell- Engaging BiTE Antibodies 5
0.5 mm short 120 degree angled tip with black ebonized shaft. Titanium handle with position reference indicator. Shaft length 52 mm, handle length 100 mm....
The popular Bechert nucleus rotator has been modified to have the shaft angled 10 mm from tip to bend for ease of manipulation of the lens nucleus in the anterior chamber. Round knurled handle....
... Multi-purpose manipulator with broad tip ... the nucleus during phacoemulsification. The ... through the side port incision ... to guide the lens down ...
1.0 mm long 90 degree angled tip with black ebonized shaft. Titanium handle with position reference indicator. Shaft length 52 mm, handle length 100 mm....
Medicine Products: